Claire Feeney

2.5k total citations · 2 hit papers
48 papers, 1.7k citations indexed

About

Claire Feeney is a scholar working on Dermatology, Immunology and Allergy and Physiology. According to data from OpenAlex, Claire Feeney has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 19 papers in Immunology and Allergy and 13 papers in Physiology. Recurrent topics in Claire Feeney's work include Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (12 papers). Claire Feeney is often cited by papers focused on Dermatology and Skin Diseases (29 papers), Allergic Rhinitis and Sensitization (17 papers) and Asthma and respiratory diseases (12 papers). Claire Feeney collaborates with scholars based in United Kingdom, United States and Denmark. Claire Feeney's co-authors include Hernán Valdez, Ricardo Rojo, Eric L. Simpson, Pinaki Biswas, Jacob P. Thyssen, Marco DiBonaventura, Carsten Flohr, Jonathan I. Silverberg, Anthony P. Goldstone and Gary Chan and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Claire Feeney

43 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

2020 313 citations Eric L. Simpson, Michael J. Cork et al. profile →
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

2020 289 citations Jonathan I. Silverberg, Eric L. Simpson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Claire Feeney	956	687	373	303	245	48	1.7k
Franck Skobieranda	148 0.2×	311 0.5×	1.6k 4.2×	84 0.3×	36 0.1×	47	3.3k
Aaron Deykin	30 0.0×	119 0.2×	1.3k 3.4×	207 0.7×	253 1.0×	52	2.4k
Laura Bazzichi	83 0.1×	24 0.0×	431 1.2×	219 0.7×	64 0.3×	74	1.9k
Jon Lampa	27 0.0×	83 0.1×	339 0.9×	1.1k 3.5×	129 0.5×	73	2.4k
Delia Colombo	66 0.1×	23 0.0×	70 0.2×	142 0.5×	274 1.1×	47	955
Doris Bach	87 0.1×	42 0.1×	52 0.1×	33 0.1×	692 2.8×	38	2.4k
David C. Broadway	66 0.1×	48 0.1×	59 0.2×	53 0.2×	128 0.5×	99	4.5k
Fariborz Mobarrez	18 0.0×	61 0.1×	170 0.5×	197 0.7×	104 0.4×	79	1.9k
Cristina Iannuccelli	23 0.0×	36 0.1×	219 0.6×	497 1.6×	44 0.2×	58	1.5k
Tommaso Aversa	27 0.0×	84 0.1×	181 0.5×	59 0.2×	18 0.1×	111	1.8k

Countries citing papers authored by Claire Feeney

Since Specialization

Citations

This map shows the geographic impact of Claire Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Feeney more than expected).

Fields of papers citing papers by Claire Feeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Feeney. The network helps show where Claire Feeney may publish in the future.

Co-authorship network of co-authors of Claire Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Feeney. A scholar is included among the top collaborators of Claire Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Feeney. Claire Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Armstrong, April W., Melinda Gooderham, Kilian Eyerich, et al.. (2024). 52741 Efficacy of Abrocitinib Versus Dupilumab on Dermatitis in the Head-and-Neck Region of Patients With Moderate-To-Severe Atopic Dermatitis: A Post Hoc Analysis of the Phase 3 JADE DARE Study. Journal of the American Academy of Dermatology. 91(3). AB36–AB36.

Thyssen, Jacob P., Jonathan I. Silverberg, Juan Ruano, et al.. (2024). Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN. Journal of the European Academy of Dermatology and Venereology. 38(11). 2130–2138.

Feeney, Claire, Vickie Lee, Parizad Avari, et al.. (2024). Extraocular muscle Diffusion Weighted Imaging as a quantitative metric of posterior orbital involvement in thyroid associated orbitopathy. Insights into Imaging. 15(1). 183–183. 5 indexed citations

Staumont‐Sallé, D., S. Barbarot, Jean‐David Bouaziz, et al.. (2023). Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis. SHILAP Revista de lepidopterología. 2(3). 518–530.

Yosipovitch, Gil, Melinda Gooderham, Sonja Ständer, et al.. (2023). Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2. American Journal of Clinical Dermatology. 25(1). 127–138. 7 indexed citations

Reich, Kristian, Jonathan I. Silverberg, Marjolein de Bruin‐Weller, et al.. (2023). 44042 Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study. Journal of the American Academy of Dermatology. 89(3). AB116–AB116. 1 indexed citations

Simpson, Eric L., Jonathan I. Silverberg, Jacob P. Thyssen, et al.. (2023). Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial. American Journal of Clinical Dermatology. 24(4). 609–621. 14 indexed citations

Lusignan, Simon de, Helen Alexander, John Dennis, et al.. (2022). Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study. Journal of Allergy and Clinical Immunology. 150(3). 709–713. 40 indexed citations

Wu, Jashin J., Chih-ho Hong, Joseph F. Merola, et al.. (2022). Predictors of nonresponse to dupilumab in patients with atopic dermatitis. Annals of Allergy Asthma & Immunology. 129(3). 354–359.e5. 16 indexed citations

10.

Silverberg, Jonathan I., Jacob P. Thyssen, Eric L. Simpson, et al.. (2021). Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes. American Journal of Clinical Dermatology. 22(4). 541–554. 32 indexed citations

11.

Blauvelt, Andrew, Jonathan I. Silverberg, Charles Lynde, et al.. (2021). Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial. Journal of the American Academy of Dermatology. 86(1). 104–112. 89 indexed citations

12.

Feeney, Claire, Vickie Lee, Sonali Nagendran, et al.. (2021). A ‘Real Life’ Service Evaluation Model for Multidisciplinary Thyroid Eye Services. Frontiers in Endocrinology. 12. 669871–669871. 2 indexed citations

13.

Feeney, Claire, et al.. (2020). Non-EPI-DWI for Detection, Disease Monitoring, and Clinical Decision-Making in Thyroid Eye Disease. American Journal of Neuroradiology. 41(8). 1466–1472. 32 indexed citations

14.

Alexander, Helen, et al.. (2019). 089 Atopic Dermatitis Is Associated With an Increased Risk of Autoimmune Diseases: A Population-Based Cohort Study Using UK Primary Care Data. Journal of Investigative Dermatology. 139(9). S229–S229. 1 indexed citations

15.

Feeney, Claire, Kevin G. Buell, Parizad Avari, et al.. (2018). Addisonian crisis: assessment and management. British Journal of Hospital Medicine. 79(3). C34–C37. 2 indexed citations

16.

Feeney, Claire, et al.. (2018). Hypophosphatasia and the importance of the general dental practitioner – a case series and discussion of upcoming treatments. BDJ. 224(12). 937–943. 21 indexed citations

17.

Tan, Chin Lik, Stephanie E Baldeweg, Antonio Belli, et al.. (2017). The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance. Journal of Neurology Neurosurgery & Psychiatry. 88(11). 971–981. 64 indexed citations

18.

Feeney, Claire, Gregory Scott, Joel Raffel, et al.. (2016). Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 43(12). 2201–2210. 56 indexed citations

19.

Feeney, Claire, et al.. (2012). Renal calculi as a presenting feature in a patient with familial hypocalciuric hypercalcaemia (FHH).. Endocrine Abstracts. 28. 2 indexed citations

20.

Walsh, Jeremy, Claire Feeney, Juliette Hussey, & Claire Donnellan. (2010). Sources of stress and psychological morbidity among undergraduate physiotherapy students. Physiotherapy. 96(3). 206–212. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact